{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:13:44Z","timestamp":1794075224099,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175090"],"award-info":[{"award-number":["175090"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13760-018-0962-4","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T08:27:25Z","timestamp":1528705645000},"page":"589-595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Factors associated with deterioration of health-related quality of life in multiple system atrophy: 1-year follow-up study"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4255-7192","authenticated-orcid":false,"given":"Milica V.","family":"Jecmenica-Lukic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana D.","family":"Pekmezovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor N.","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa T.","family":"Dragasevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir S.","family":"Kosti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"962_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning G (2015) Multiple-system atrophy. N Engl J Med 372:249\u2013263","journal-title":"N Engl J Med"},{"issue":"16","key":"962_CR2","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/mds.21734","volume":"22","author":"S May","year":"2007","unstructured":"May S, Gilman S, Sowell BB et al (2007) Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord 22(16):2371\u20132377","journal-title":"Mov Disord"},{"issue":"6","key":"962_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/mds.20808","volume":"21","author":"A Schrag","year":"2006","unstructured":"Schrag A, Geser F, Stampfer-Kountchev M et al (2006) Health-related quality of life in multiple system atrophy. Mov Disord 21(6):809\u2013815","journal-title":"Mov Disord"},{"issue":"6","key":"962_CR4","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11136-012-0269-5","volume":"22","author":"M Calvert","year":"2013","unstructured":"Calvert M, Pall H, Hoppitt T, Eaton B, Savill E, Sackley C (2013) Health-related quality of life and supportive care in patients with rare long-term neurological conditions. Qual Life Res 22(6):1573\u20132649","journal-title":"Qual Life Res"},{"issue":"1","key":"962_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1468-1331.2006.01554.x","volume":"14","author":"M K\u00f6llensperger","year":"2007","unstructured":"K\u00f6llensperger M, Stampfer-Kountchev M, Seppi K et al (2007) Progression of dysautonomia in multiple system atrophy: A prospective study of self-perceived impairment. Eur J Neurol 14(1):66\u201372","journal-title":"Eur J Neurol"},{"issue":"6","key":"962_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF02309628","volume":"8","author":"S Gilman","year":"1998","unstructured":"Gilman S, Low P, Quinn N, Albanese A et al (1998) Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 8(6):359\u2013362","journal-title":"Clin Auton Res"},{"issue":"3","key":"962_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"962_CR8","unstructured":"SF-36 Health Survey (Original version) Language Recalls. \n                    http:\/\/www.qualitymetric.com\n                    \n                  . Accessed Jan 2018"},{"issue":"2","key":"962_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1212\/WNL.50.2.318","volume":"57","author":"M Hoehn","year":"1967","unstructured":"Hoehn M, Yahr M (1967) Parkinsonism: onset, progression, and mortality. Neurology 57(2):318\u2013334","journal-title":"Neurology"},{"key":"962_CR10","first-page":"153","volume-title":"Recent developments in Parkinson\u2019s disease II","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson\u2019s disease rating scale. In: Fahn S, Goldstein M, Calne DB (eds) Recent developments in Parkinson\u2019s disease II. MacMillan, New York, pp\u00a0153\u2013163"},{"issue":"12","key":"962_CR11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/mds.20255","volume":"19","author":"GK Wenning","year":"2004","unstructured":"Wenning GK, Tison F, Seppi K et al (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 19(12):1391\u20131402","journal-title":"Mov Disord"},{"key":"962_CR12","first-page":"56","volume":"23","author":"MC Hamilton","year":"1960","unstructured":"Hamilton MC (1960) Hamilton Depression Rating Scale (HAM-D). Redloc 23:56\u201362","journal-title":"Redloc"},{"issue":"4","key":"962_CR13","first-page":"81","volume":"61","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) Hamilton Anxiety Rating Scale (HAM-A). J Med 61(4):81\u201382","journal-title":"J Med"},{"issue":"2","key":"962_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1176\/jnp.4.2.134","volume":"4","author":"SE Starkstein","year":"1992","unstructured":"Starkstein SE, Mayberg SE, Preziosi TJ et al (1992) Reliability, validity, and clinical correlates of apathy in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 4(2):134\u2013139","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"962_CR15","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308\u20132314","journal-title":"Neurology"},{"issue":"11","key":"962_CR16","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/gps.1610","volume":"21","author":"E Mioshi","year":"2006","unstructured":"Mioshi E, Dawson K, Mitchell J et al (2006) The Addenbrooke\u2019s cognitive examination revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21(11):1078\u20131085","journal-title":"Int J Geriatr Psychiatry"},{"issue":"11","key":"962_CR17","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55(11):1621\u20131626","journal-title":"Neurology"},{"issue":"11","key":"962_CR18","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser M, Marinus J, Stiggelbout AM et al (2004) Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT. Mov Disord 19(11):1306\u20131312","journal-title":"Mov Disord"},{"key":"962_CR19","volume-title":"SF-36 health survey manual and interpretation guide","author":"JE Ware","year":"1993","unstructured":"Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36 health survey manual and interpretation guide. New England Medical Center, Boston"},{"key":"962_CR20","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd\u00a0edn. Academic Press, New York","edition":"2"},{"issue":"8","key":"962_CR21","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.22794","volume":"25","author":"A Schrag","year":"2010","unstructured":"Schrag A, Sheikh S, Quinn NP et al (2010) A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Mov Disord 25(8):1077\u20131081","journal-title":"Mov Disord"},{"issue":"6","key":"962_CR22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000325829","volume":"8","author":"Y Winter","year":"2011","unstructured":"Winter Y, Spottke AE, Stamelou M et al (2011) Health-related quality of life in multiple system atrophy and progressive supranuclear palsy. Neurodegener Dis 8(6):438\u2013446","journal-title":"Neurodegener Dis"},{"issue":"5","key":"962_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/brb3.320","volume":"5","author":"L Kass-Iliyya","year":"2015","unstructured":"Kass-Iliyya L, Kobylecki C, Mcdonald KR et al (2015) Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson\u2019s disease. Brain Behav 5(5):2\u20135","journal-title":"Brain Behav"},{"issue":"1","key":"962_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00415-009-5255-7","volume":"257","author":"C Colosimo","year":"2010","unstructured":"Colosimo C, Morgante L, Antonini A et al (2010) Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 257(1):5\u201314","journal-title":"J Neurol"},{"issue":"8","key":"962_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/mds.20450","volume":"20","author":"LM Benrud-Larson","year":"2005","unstructured":"Benrud-Larson LM, Sandroni P, Schrag A, Low PA (2005) Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov Disord 20(8):951\u2013957","journal-title":"Mov Disord"},{"issue":"9","key":"962_CR26","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s00415-015-7815-3","volume":"262","author":"T Pekmezovic","year":"2015","unstructured":"Pekmezovic T, Jecmenica-Lukic M, Petrovic I et al (2015) Quality of life in patients with progressive supranuclear palsy: one-year follow-up. J Neurol 262(9):2042\u20132048","journal-title":"J Neurol"},{"issue":"12","key":"962_CR27","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/mds.25174","volume":"27","author":"WG Meissner","year":"2012","unstructured":"Meissner WG, Foubert-Samier A, Dupouy S et al (2012) Assessment of quality of life with the multiple system atrophy health-related quality of life scale. Mov Disord 27(12):1574\u20131577","journal-title":"Mov Disord"},{"issue":"3","key":"962_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","volume":"12","author":"GK Wenning","year":"2013","unstructured":"Wenning GK, Geser F, Krismer F et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12(3):264\u2013274","journal-title":"Lancet Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-018-0962-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-018-0962-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-018-0962-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T19:12:45Z","timestamp":1560193965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-018-0962-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1007\/s13760-018-0962-4","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"assertion":[{"value":"25 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MJL declare no conflict of interests. TP reports grants from the Ministry of Education, Science and Technological Development of the Republic of Serbia (Project nos. 175087 and 175090). IP has received speaker honoraria from GlaxoSmithKline, Boehringer Ingelheim, and El pharma. ND has received speaker honoraria from Boehringer Ingelheim. VK receives research support from the Ministry of Education, Science and Technological Development of the Republic of Serbia (Project no. 175090) and Serbian Academy of Sciences and Arts, as well as research grants from Stada, Valeant, Boehringer Ingelheim, and Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research presented in this study was approved by local Ethics Committees. The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}},{"value":"Informed consent was obtained from each patient prior to their inclusion in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}